FDA Panel Backs First-Of-A-Kind COVID-19 Pill from Merck
A U.S. Food and Drug Administration panel voted 13-10 that the drug’s benefits outweigh its risks.
This article was republished here with permission from The Associated Press, however it is no longer available to read on Snopes.com.
WASHINGTON (AP) — A panel of U.S. health advisers narrowly backed a closely watched COVID-19 pill from Merck, setting the stage for a likely authorization of the first drug that Americans could take at home to treat the coronavirus. A Food and Drug Administration panel voted 13-10 that the drug’s benefits outweigh its risks, including potential birth defects if used during pregnancy. The recommendation came after hours of debate about the drug’s modest benefits and…